Inhibitors in hemophilia A: are some products safer?
Briët
E
E
Hemostasis and Thrombosis Research Center, Department of Hematology, Leiden, The Netherlands.
Rosendaal
F R
FR
D002986:Clinical Trials as Topic; D005169:Factor VIII / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000276:immunology; D006467:Hemophilia A / Q000276:immunology*; D006801:Humans; D012307:Risk Factors
D005169:Factor VIII